AARTI PHARMALABS
Back to Income Statement
|
AARTI PHARMALABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,853 Cr | ₹1,945 Cr | ₹1,200 Cr | - | - |
What is the latest Revenue of AARTI PHARMALABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,853 Cr |
| Mar2024 | ₹1,945 Cr |
| Mar2023 | ₹1,200 Cr |
| Mar2022 | - |
| Mar2021 | - |
How is Revenue of AARTI PHARMALABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,853 Cr | -4.76 | |
| Mar2024 | ₹1,945 Cr | 62.11 | |
| Mar2023 | ₹1,200 Cr | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Revenue of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹5,850.6 Cr | 2.6% | -10.6% | -16.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 2.6% |
-10.6% |
-16.4% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses